Robert O. Dillman

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

Robert O. Dillman, Stephen L. Seagren, Kathleen J. Propert et al. · New England Journal of Medicine · 1990 · 1.2K citations · Full text

Human immune response to multiple injections of murine monoclonal IgG.

Daniel L. Shawler, Richard M. Bartholomew, Leia M. Smith et al. · The Journal of Immunology · 1985 · 426 citations · Full text

Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non–Small-Cell Lung Cancer

John Nemunaitis, Robert O. Dillman, Paul Schwarzenberger et al. · Journal of Clinical Oncology · 2006 · 358 citations · Full text

Single-Agent Monoclonal Antibody Efficacy in Bulky Non-Hodgkin's Lymphoma: Results of a Phase II Trial of Rituximab

Thomas A. Davis, Christine A. White, A.J. Grillo-López et al. · Journal of Clinical Oncology · 1999 · 289 citations

Immunology, Immunotherapy, Hematological Malignancy +16

Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.

Robert O. Dillman, Daniel L. Shawler, Jacquelyn B. Dillman et al. · Journal of Clinical Oncology · 1984 · 175 citations

Chronic Lymphocytic Leukemia, Immunology, Pathology +16